Cameron A, Sun P, Lage M
Outcomes Research, Eli Lilly and Company, Lilly Corporate Center, Drop Code 1833, Indianapolis, IN 46285, USA.
Int J Impot Res. 2006 Jul-Aug;18(4):375-81. doi: 10.1038/sj.ijir.3901439. Epub 2006 Jan 5.
Although erectile dysfunction (ED) has been considered a complication of other medical conditions, clinicians and researchers suggest that ED may serve as a clinical marker of vascular health. This retrospective claims study examined the prevalence of predefined comorbid conditions in men with ED (N=301 994) in the 12 months before and the 6 months following ED diagnosis. Consistent with previous research, comorbid conditions were prevalent among men with ED. Comorbid conditions were most often diagnosed before an ED diagnosis, although new diagnoses in the 6 months following an ED diagnosis were common and occured more frequently than new diagnoses in a matched sample of men without ED during the same period. Differences by age, region and insurance coverage for ED medications were also examined. Findings support previous research that suggests ED may serve as a marker for previously undetected comorbid conditions.
尽管勃起功能障碍(ED)一直被视为其他疾病的并发症,但临床医生和研究人员认为,ED可能是血管健康的临床指标。这项回顾性索赔研究调查了ED患者(N = 301994)在ED诊断前12个月和诊断后6个月内预先定义的共病情况的患病率。与先前的研究一致,共病在ED男性中很普遍。共病最常在ED诊断之前被诊断出来,不过在ED诊断后的6个月内新诊断也很常见,并且比同期未患ED的匹配样本中的新诊断更频繁。还研究了年龄、地区和ED药物保险覆盖范围的差异。研究结果支持了先前的研究,即ED可能是先前未被发现的共病情况的一个指标。